{"id":"W2612613166","doi":"10.1002/14651858.cd012657","title":"Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"National Cancer Institute; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Agency for Healthcare Research and Quality","keywords":"Medicine; Golimumab; Adalimumab; Tofacitinib; Etanercept; Abatacept; Infliximab; Tocilizumab; Rheumatoid arthritis; Certolizumab pegol; Internal medicine; Meta-analysis; Randomized controlled trial; Number needed to treat; Odds ratio; Confidence interval; Physical therapy; Relative risk; Rituximab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.01557911,0.001523462,0.06633636,0.0006207942,0.0003456071,0.000210507,0.001112295,0.0002745281,0.0005180548],"category_scores_gemma":[0.01990867,0.000697102,0.005767601,0.001598561,0.0002382177,0.0002387981,0.0003153869,0.0004308435,0.0001332944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007044687,"about_ca_system_score_gemma":0.0004635072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000047554,"about_ca_topic_score_gemma":0.0002108105,"domain_scores_codex":[0.9853857,0.004242579,0.007126879,0.001361446,0.001008509,0.0008749564],"domain_scores_gemma":[0.9816965,0.004609734,0.00687422,0.005173466,0.0009353345,0.0007107077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003988674,0.00006537124,5.215468e-7,0.8967467,0.09914735,0.00004645312,0.00006226221,1.056951e-7,1.17045e-7,0.0001193383,0.001838534,0.001933385],"study_design_scores_gemma":[0.0004107037,0.0003799582,5.141561e-8,0.6777365,0.2554056,0.001048708,0.0000353168,0.000003767849,2.569771e-7,0.000003261495,0.06449805,0.0004778385],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[2.389271e-7,0.9265892,0.002324875,0.00009378635,0.00005480295,0.06704234,0.003799057,0.00004634334,0.00004938867],"genre_scores_gemma":[9.041714e-7,0.9504353,0.009162636,0.0002127734,0.0000407407,0.03721774,0.002376448,0.0001224407,0.0004309599],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2190102,"threshold_uncertainty_score":0.9997514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2459682699240482,"score_gpt":0.4355907064752449,"score_spread":0.1896224365511967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}